share_log

HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $7 Price Target

Moomoo 24/7 ·  Mar 18 07:02

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $7 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment